Medinova Diagnostic Services Approves Merger with Vijaya Diagnostic Centre
Medinova Diagnostic Service Limited's Board has approved Q2 and H1 FY2026 financial results and a merger with Vijaya Diagnostic Centre. The NCLT sanctioned the amalgamation on October 13, 2025, with shareholders receiving 1 equity share in Vijaya for every 22 Medinova shares. The merger's appointed date is April 1, 2024, with a record date of November 25, 2025. Medinova's H1 FY2026 consolidated results show 3.30% revenue growth to INR 521.81 lakhs and 27.78% net profit increase to INR 117.56 lakhs. The company's balance sheet improved with total assets of INR 761.97 lakhs and reduced negative equity.

*this image is generated using AI for illustrative purposes only.
Medinova Diagnostic Service Limited (Medinova) has taken a significant step towards consolidation in the diagnostic services sector. The company's Board of Directors has approved the unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2025, alongside a major corporate restructuring move.
Merger Approval and Terms
The company received sanction from the National Company Law Tribunal (NCLT), Hyderabad, on October 13, 2025, for its amalgamation scheme with Vijaya Diagnostic Centre Limited. Under the terms of the merger:
- Shareholders of Medinova will receive 1 equity share of INR 1 face value in Vijaya Diagnostic Centre for every 22 equity shares of INR 10 face value held in Medinova Diagnostics.
- The appointed date for the merger is set as April 1, 2024.
- The record date to determine eligible shareholders is November 25, 2025.
Financial Performance
Medinova's financial results for Q2 and H1 FY2026 showcase a robust performance:
Consolidated Results (H1 FY2026)
| Particulars | Amount (INR in Lakhs) | YoY Growth |
|---|---|---|
| Revenue from Operations | 521.81 | 3.30% |
| Total Income | 530.48 | 4.15% |
| Profit Before Tax | 177.14 | 45.40% |
| Net Profit | 117.56 | 27.78% |
Key Highlights
- The company witnessed a significant improvement in profitability, with net profit increasing by 27.78% year-over-year.
- Operating revenue grew by 3.30%, indicating steady business performance.
- Earnings per share (EPS) for the half-year stood at INR 1.18, up from INR 0.92 in the same period last year.
Balance Sheet Strength
As of September 30, 2025, Medinova's consolidated balance sheet reflects:
- Total assets of INR 761.97 lakhs
- A notable improvement in the equity position, with the negative equity reduced to INR 8.33 lakhs from INR 124.79 lakhs as of March 31, 2025
Merger Implications
The amalgamation with Vijaya Diagnostic Centre is expected to create synergies in the diagnostic services sector. This strategic move may lead to:
- Enhanced market presence
- Operational efficiencies
- Expanded service offerings
The merger will be effective upon filing the certified copy of NCLT's order with the Registrar of Companies, Hyderabad.
Looking Ahead
As Medinova Diagnostic Services prepares for this transition, the focus will likely be on integration and leveraging combined strengths. Stakeholders will be watching closely how this merger impacts the competitive landscape in the diagnostic services industry.
The company's improved financial performance, coupled with the strategic merger, positions Medinova for potential growth in the evolving healthcare diagnostics market.
Historical Stock Returns for Medinova Diagnostic Service
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.47% | +3.87% | +0.85% | -2.44% | +9.46% | +223.29% |





























